Valuation Update With 7 Day Price Move • May 20
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to ₹891, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 89% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,222 per share. Buy Or Sell Opportunity • May 18
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 28% to ₹905. The fair value is estimated to be ₹1,170, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 47%. Revenue is forecast to grow by 26% in 2 years. Earnings are forecast to grow by 9.1% in the next 2 years. Reported Earnings • May 14
Full year 2026 earnings: EPS exceeds analyst expectations Full year 2026 results: EPS: ₹75.47 (up from ₹33.74 in FY 2025). Revenue: ₹53.7b (up 24% from FY 2025). Net income: ₹6.81b (up 124% from FY 2025). Profit margin: 13% (up from 7.0% in FY 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 16%. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Announcement • May 05
Sharda Cropchem Limited to Report Q4, 2026 Results on May 13, 2026 Sharda Cropchem Limited announced that they will report Q4, 2026 results on May 13, 2026 Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹1,049, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 135% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹663 per share. Price Target Changed • Jan 31
Price target increased by 7.4% to ₹1,252 Up from ₹1,165, the current price target is an average from 5 analysts. New target price is 20% above last closing price of ₹1,040. Stock is up 85% over the past year. The company is forecast to post earnings per share of ₹62.76 for next year compared to ₹33.74 last year. Reported Earnings • Jan 30
Third quarter 2026 earnings released: EPS: ₹16.09 (vs ₹3.45 in 3Q 2025) Third quarter 2026 results: EPS: ₹16.09 (up from ₹3.45 in 3Q 2025). Revenue: ₹12.9b (up 39% from 3Q 2025). Net income: ₹1.45b (up 366% from 3Q 2025). Profit margin: 11% (up from 3.4% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 29% per year and the company’s share price has also increased by 29% per year. New Risk • Jan 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.1% average weekly change). Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹987, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 110% over the past three years. Announcement • Jan 20
Sharda Cropchem Limited to Report Q3, 2026 Results on Jan 29, 2026 Sharda Cropchem Limited announced that they will report Q3, 2026 results on Jan 29, 2026 Reported Earnings • Nov 01
Second quarter 2026 earnings released: EPS: ₹8.24 (vs ₹4.70 in 2Q 2025) Second quarter 2026 results: EPS: ₹8.24 (up from ₹4.70 in 2Q 2025). Revenue: ₹9.58b (up 23% from 2Q 2025). Net income: ₹743.1m (up 75% from 2Q 2025). Profit margin: 7.8% (up from 5.5% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 29% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 21
Sharda Cropchem Limited to Report Q2, 2026 Results on Oct 30, 2025 Sharda Cropchem Limited announced that they will report Q2, 2026 results at 9:08 AM, Indian Standard Time on Oct 30, 2025 Upcoming Dividend • Jul 31
Upcoming dividend of ₹6.00 per share Eligible shareholders must have bought the stock before 07 August 2025. Payment date: 13 September 2025. Payout ratio is a comfortable 27% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). Price Target Changed • Jul 29
Price target increased by 33% to ₹1,032 Up from ₹776, the current price target is an average from 5 analysts. New target price is 11% below last closing price of ₹1,154. Stock is up 107% over the past year. The company is forecast to post earnings per share of ₹54.33 for next year compared to ₹33.74 last year. Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to ₹1,088, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 115% over the past three years. Announcement • Jul 17
Sharda Cropchem Limited to Report Q1, 2026 Results on Jul 25, 2025 Sharda Cropchem Limited announced that they will report Q1, 2026 results on Jul 25, 2025 Reported Earnings • Jul 16
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: ₹33.74 (up from ₹3.53 in FY 2024). Revenue: ₹43.2b (up 37% from FY 2024). Net income: ₹3.04b (up ₹2.72b from FY 2024). Profit margin: 7.0% (up from 1.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 8.6%. Earnings per share (EPS) also surpassed analyst estimates by 12%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹919, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 46% over the past three years. Declared Dividend • Jul 03
Final dividend increased to ₹6.00 Dividend of ₹6.00 is 100% higher than last year. Ex-date: 7th August 2025 Payment date: 13th September 2025 Dividend yield will be 1.0%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is covered by both earnings (27% earnings payout ratio) and cash flows (51% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 44% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Announcement • Jul 02
Sharda Cropchem Limited, Annual General Meeting, Aug 14, 2025 Sharda Cropchem Limited, Annual General Meeting, Aug 14, 2025, at 13:00 Indian Standard Time. New Risk • Jun 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.5% average weekly change). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Valuation Update With 7 Day Price Move • May 28
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹736, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 8.3% over the past three years. Reported Earnings • May 15
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: ₹33.74 (up from ₹3.53 in FY 2024). Revenue: ₹43.8b (up 39% from FY 2024). Net income: ₹3.04b (up ₹2.72b from FY 2024). Profit margin: 7.0% (up from 1.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 8.6%. Earnings per share (EPS) also surpassed analyst estimates by 12%. Revenue is forecast to grow 9.0% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Announcement • May 05
Sharda Cropchem Limited to Report Q4, 2025 Results on May 14, 2025 Sharda Cropchem Limited announced that they will report Q4, 2025 results on May 14, 2025 Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹481, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 31% over the past three years. New Risk • Mar 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.1% average weekly change). Upcoming Dividend • Jan 30
Upcoming dividend of ₹3.00 per share Eligible shareholders must have bought the stock before 06 February 2025. Payment date: 23 February 2025. Payout ratio is on the higher end at 85%, however this is supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%). Reported Earnings • Jan 25
Third quarter 2025 earnings released: EPS: ₹3.45 (vs ₹0.51 in 3Q 2024) Third quarter 2025 results: EPS: ₹3.45 (up from ₹0.51 in 3Q 2024). Revenue: ₹9.30b (up 47% from 3Q 2024). Net income: ₹311.5m (up ₹265.1m from 3Q 2024). Profit margin: 3.3% (up from 0.7% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Announcement • Jan 25
Sharda Cropchem Limited Provides Earnings Guidance for the Year 2025 Sharda Cropchem Limited provided earnings guidance for the year 2025. The company expects to achieve INR 40,000 million in revenue. Announcement • Jan 16
Sharda Cropchem Limited to Report Q3, 2025 Results on Jan 24, 2025 Sharda Cropchem Limited announced that they will report Q3, 2025 results on Jan 24, 2025 Valuation Update With 7 Day Price Move • Jan 14
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹725, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 106% over the past three years. New Risk • Jan 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.4% average weekly change). Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₹755, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 149% over the past three years. Price Target Changed • Oct 29
Price target increased by 16% to ₹738 Up from ₹638, the current price target is an average from 5 analysts. New target price is 13% above last closing price of ₹654. Stock is up 61% over the past year. The company is forecast to post earnings per share of ₹29.20 for next year compared to ₹3.53 last year. Reported Earnings • Oct 26
Second quarter 2025 earnings released: EPS: ₹4.70 (vs ₹3.06 loss in 2Q 2024) Second quarter 2025 results: EPS: ₹4.70 (up from ₹3.06 loss in 2Q 2024). Revenue: ₹7.77b (up 34% from 2Q 2024). Net income: ₹424.1m (up ₹699.9m from 2Q 2024). Profit margin: 5.5% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings. Announcement • Oct 17
Sharda Cropchem Limited to Report Q2, 2025 Results on Oct 24, 2024 Sharda Cropchem Limited announced that they will report Q2, 2025 results on Oct 24, 2024 Announcement • Aug 10
Sharda Cropchem Limited Approves Dividend for Financial Year 2023-2024 Sharda Cropchem Limited at its AGM held on August 9, 2024, approved dividend at the rate of INR 3.00 per equity share of face value of INR 10.00 each for financial year 2023-24. Announcement • Aug 09
Sharda Cropchem Limited Announces Directorate Cessation Sharda Cropchem Limited informed that the following Non-Executive Independent Directors of the Company have completed their second (2) term of 5 years in the Company on 8th August, 2024 and consequently have ceased as Directors of the Company with effect from 8th August, 2024. Mr. M. S. Sundara Rajan:Non-Executive Independent Director, Mr. Shitin Desai: Non-Executive Independent Director, Mr. Shobhan Thakore:Non-Executive Independent Director. Upcoming Dividend • Jul 26
Upcoming dividend of ₹3.00 per share Eligible shareholders must have bought the stock before 02 August 2024. Payment date: 08 September 2024. Payout ratio is on the higher end at 85%, however this is supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%). Announcement • Jul 16
Sharda Cropchem Limited to Report Q1, 2025 Results on Jul 23, 2024 Sharda Cropchem Limited announced that they will report Q1, 2025 results on Jul 23, 2024 Reported Earnings • Jul 11
Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2024 results: EPS: ₹3.53 (down from ₹37.90 in FY 2023). Revenue: ₹31.6b (down 22% from FY 2023). Net income: ₹318.8m (down 91% from FY 2023). Profit margin: 1.0% (down from 8.5% in FY 2023). Revenue missed analyst estimates by 11%. Earnings per share (EPS) exceeded analyst estimates by 64%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • Jul 05
Sharda Cropchem Limited, Annual General Meeting, Aug 09, 2024 Sharda Cropchem Limited, Annual General Meeting, Aug 09, 2024, at 13:00 Indian Standard Time. Declared Dividend • Jul 05
Dividend of ₹3.00 announced Shareholders will receive a dividend of ₹3.00. Ex-date: 2nd August 2024 Payment date: 8th September 2024 Dividend yield will be 0.6%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by both earnings (85% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has increased by an average of 2.0% per year over the past 9 years. However, payments have been volatile during that time. EPS is expected to grow by 205% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Price Target Changed • Jun 28
Price target increased by 9.8% to ₹521 Up from ₹475, the current price target is an average from 5 analysts. New target price is 17% above last closing price of ₹447. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₹24.78 for next year compared to ₹3.53 last year. Price Target Changed • Jun 13
Price target increased by 7.4% to ₹475 Up from ₹442, the current price target is an average from 6 analysts. New target price is 10% above last closing price of ₹431. Stock is down 22% over the past year. The company is forecast to post earnings per share of ₹24.78 for next year compared to ₹3.53 last year. Announcement • May 16
Sharda Cropchem Limited Provides Earnings Guidance for the Fiscal Year 2025 Sharda Cropchem Limited provided earnings guidance for the fiscal year 2025. Going ahead for the fiscal year 2025, the company expects revenues to grow by 12% to 15%. Reported Earnings • May 11
Full year 2024 earnings released: EPS: ₹3.53 (vs ₹37.90 in FY 2023) Full year 2024 results: EPS: ₹3.53 (down from ₹37.90 in FY 2023). Revenue: ₹32.2b (down 20% from FY 2023). Net income: ₹318.8m (down 91% from FY 2023). Profit margin: 1.0% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Announcement • May 11
Sharda Cropchem Limited Proposes Dividend for Financial Year 2023-2024 Sharda Cropchem Limited at its board meeting held on 10 May 2024, considered and recommended dividend at the rate of INR 3.00 per equity share of face value of INR 10.00 each for financial year 2023-24, subject to the approval of the shareholders at the forthcoming Annual General Meeting of the Company. Announcement • May 05
Sharda Cropchem Limited to Report Q4, 2024 Results on May 10, 2024 Sharda Cropchem Limited announced that they will report Q4, 2024 results on May 10, 2024 Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹370, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹543 per share. Buy Or Sell Opportunity • Feb 05
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.7% to ₹381. The fair value is estimated to be ₹477, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has declined by 7.2%. Revenue is forecast to grow by 39% in 2 years. Earnings are forecast to grow by 260% in the next 2 years. Price Target Changed • Jan 28
Price target decreased by 7.7% to ₹470 Down from ₹509, the current price target is an average from 7 analysts. New target price is 18% above last closing price of ₹398. Stock is down 19% over the past year. The company is forecast to post earnings per share of ₹15.13 for next year compared to ₹37.90 last year. Reported Earnings • Jan 25
Third quarter 2024 earnings released: EPS: ₹0.51 (vs ₹12.01 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.51 (down from ₹12.01 in 3Q 2023). Revenue: ₹6.45b (down 37% from 3Q 2023). Net income: ₹46.4m (down 96% from 3Q 2023). Profit margin: 0.7% (down from 11% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Announcement • Jan 17
Sharda Cropchem Limited to Report Q3, 2024 Results on Jan 24, 2024 Sharda Cropchem Limited announced that they will report Q3, 2024 results on Jan 24, 2024 Price Target Changed • Oct 25
Price target decreased by 8.4% to ₹530 Down from ₹579, the current price target is an average from 7 analysts. New target price is 29% above last closing price of ₹412. Stock is down 1.2% over the past year. The company is forecast to post earnings per share of ₹18.85 for next year compared to ₹37.90 last year. Reported Earnings • Oct 22
Second quarter 2024 earnings released: ₹3.06 loss per share (vs ₹1.34 profit in 2Q 2023) Second quarter 2024 results: ₹3.06 loss per share (down from ₹1.34 profit in 2Q 2023). Revenue: ₹6.04b (down 16% from 2Q 2023). Net loss: ₹275.8m (down 328% from profit in 2Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 12
Sharda Cropchem Limited to Report Q2, 2024 Results on Oct 21, 2023 Sharda Cropchem Limited announced that they will report Q2, 2024 results at 12:08 PM, Indian Standard Time on Oct 21, 2023 New Risk • Jul 25
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.0% Last year net profit margin: 8.8% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.0% net profit margin). Price Target Changed • Jul 25
Price target decreased by 8.3% to ₹631 Down from ₹688, the current price target is an average from 7 analysts. New target price is 41% above last closing price of ₹448. Stock is down 15% over the past year. The company is forecast to post earnings per share of ₹44.45 for next year compared to ₹37.90 last year. Reported Earnings • Jul 08
Full year 2023 earnings: EPS in line with expectations, revenues disappoint Full year 2023 results: EPS: ₹37.90 (down from ₹38.71 in FY 2022). Revenue: ₹40.5b (up 13% from FY 2022). Net income: ₹3.42b (down 2.1% from FY 2022). Profit margin: 8.5% (down from 9.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 24% per year whereas the company’s share price has increased by 25% per year. Announcement • Jul 04
Sharda Cropchem Limited, Annual General Meeting, Aug 08, 2023 Sharda Cropchem Limited, Annual General Meeting, Aug 08, 2023, at 14:30 Indian Standard Time. Announcement • Jun 08
Sharda Cropchem Announces Resignation of Ashok Kumar Vashisht as Chief Financial Officer Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sharda Cropchem Limited announced that Mr. Ashok Kumar Vashisht, has resigned from the post of Chief Financial Officer (CFO) of the Company due to personal reasons and his last working day will be from the closing hours of 07th June, 2023. Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹557, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 234% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹242 per share. Announcement • May 13
Sharda Cropchem Limited Recommends Final Dividend for the Financial Year 2022-23 The board of directors of Sharda Cropchem Limited of meeting held on May 12, 2023, recommended final dividend at the rate of INR 3.00 per equity share of face value of INR 10.00 each for financial year 2022-23, subject to the approval of the shareholders at the forthcoming Annual General Meeting of the Company. Reported Earnings • May 13
Full year 2023 earnings released: EPS: ₹75.80 (vs ₹38.71 in FY 2022) Full year 2023 results: EPS: ₹75.80 (up from ₹38.71 in FY 2022). Revenue: ₹81.7b (up 128% from FY 2022). Net income: ₹6.84b (up 96% from FY 2022). Profit margin: 8.4% (down from 9.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 22% p.a. on average during the next 2 years, while revenues in the Chemicals industry in India are expected to grow by 11%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 06
Sharda Cropchem Limited to Report Q4, 2023 Results on May 12, 2023 Sharda Cropchem Limited announced that they will report Q4, 2023 results on May 12, 2023 Upcoming Dividend • Jan 31
Upcoming dividend of ₹3.00 per share at 1.2% yield Eligible shareholders must have bought the stock before 07 February 2023. Payment date: 23 February 2023. Payout ratio is a comfortable 17% but the company is not cash flow positive. Trailing yield: 1.2%. Lower than top quartile of Indian dividend payers (1.6%). Higher than average of industry peers (0.9%). Announcement • Jan 25
Sharda Cropchem Limited Declares Interim Dividend for the Financial Year 2022-23, Payable on or Before February 23, 2023 The board of directors of Sharda Cropchem Limited at its meeting held on January 24, 2023, the Board of Directors considered and declared Interim Dividend at the rate of INR 3.00 per equity share of face value of INR 10.00 each for Financial Year 2022-23. The record date for the purpose of Interim Dividend will be February 7, 2023. The Interim Dividend shall be paid or dispatched on or before February 23, 2023. Reported Earnings • Jan 25
Third quarter 2023 earnings released: EPS: ₹12.01 (vs ₹11.33 in 3Q 2022) Third quarter 2023 results: EPS: ₹12.01 (up from ₹11.33 in 3Q 2022). Revenue: ₹10.2b (up 16% from 3Q 2022). Net income: ₹1.08b (up 6.1% from 3Q 2022). Profit margin: 11% (down from 12% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 28% per year whereas the company’s share price has increased by 29% per year. Announcement • Jan 17
Sharda Cropchem Limited to Report Q3, 2023 Results on Jan 24, 2023 Sharda Cropchem Limited announced that they will report Q3, 2023 results at 12:08 PM, Indian Standard Time on Jan 24, 2023 Buying Opportunity • Jan 02
Now 21% undervalued Over the last 90 days, the stock is up 15%. The fair value is estimated to be ₹634, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 38% in the next 2 years. Valuation Update With 7 Day Price Move • Dec 30
Investor sentiment improved over the past week After last week's 22% share price gain to ₹514, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 87% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹634 per share. Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improved over the past week After last week's 23% share price gain to ₹499, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 147% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹697 per share. Price Target Changed • Nov 16
Price target decreased to ₹663 Down from ₹731, the current price target is an average from 6 analysts. New target price is 66% above last closing price of ₹400. Stock is up 20% over the past year. The company is forecast to post earnings per share of ₹37.50 for next year compared to ₹38.71 last year. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 7 highly experienced directors. Independent Non-Executive Director Sonal Desai was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • Oct 28
Consensus forecasts updated The consensus outlook for 2023 has been updated. 2023 EPS estimate fell from ₹42.05 to ₹37.72 per share. Revenue forecast steady at ₹42.1b. Net income forecast to grow 21% next year vs 22% growth forecast for Chemicals industry in India. Consensus price target down from ₹778 to ₹653. Share price fell 13% to ₹388 over the past week. Buying Opportunity • Oct 26
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 20%. The fair value is estimated to be ₹541, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 27% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 38% in the next 2 years. Price Target Changed • Oct 25
Price target decreased to ₹722 Down from ₹778, the current price target is an average from 6 analysts. New target price is 66% above last closing price of ₹434. Stock is up 36% over the past year. The company is forecast to post earnings per share of ₹40.77 for next year compared to ₹38.71 last year. Reported Earnings • Oct 23
Second quarter 2023 earnings released: EPS: ₹1.34 (vs ₹3.55 in 2Q 2022) Second quarter 2023 results: EPS: ₹1.34 (down from ₹3.55 in 2Q 2022). Revenue: ₹7.32b (up 14% from 2Q 2022). Net income: ₹120.9m (down 62% from 2Q 2022). Profit margin: 1.7% (down from 5.0% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Announcement • Oct 14
Sharda Cropchem Limited to Report Q2, 2023 Results on Oct 21, 2022 Sharda Cropchem Limited announced that they will report Q2, 2023 results at 12:15 PM, Indian Standard Time on Oct 21, 2022 Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₹564, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 107% over the past three years. Upcoming Dividend • Jul 18
Upcoming dividend of ₹3.00 per share Eligible shareholders must have bought the stock before 25 July 2022. Payment date: 01 September 2022. Payout ratio is a comfortable 15% but the company is paying out more than the cash it is generating. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.8%). In line with average of industry peers (0.8%). Announcement • Jul 16
Sharda Cropchem Limited to Report Q1, 2023 Results on Jul 25, 2022 Sharda Cropchem Limited announced that they will report Q1, 2023 results at 12:15 PM, Indian Standard Time on Jul 25, 2022 Reported Earnings • Jul 07
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: ₹38.71 (up from ₹25.40 in FY 2021). Revenue: ₹35.8b (up 49% from FY 2021). Net income: ₹3.49b (up 52% from FY 2021). Profit margin: 9.8% (in line with FY 2021). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 3.0%. Over the next year, revenue is forecast to grow 14%, compared to a 17% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 28% per year and the company’s share price has also increased by 28% per year. Announcement • Jun 29
Sharda Cropchem Limited, Annual General Meeting, Aug 02, 2022 Sharda Cropchem Limited, Annual General Meeting, Aug 02, 2022, at 12:00 Indian Standard Time. Major Estimate Revision • May 20
Consensus EPS estimates increase by 11% The consensus outlook for earnings per share (EPS) in 2023 has improved. 2023 revenue forecast increased from ₹39.7b to ₹40.5b. EPS estimate increased from ₹41.87 to ₹46.58 per share. Net income forecast to grow 20% next year vs 24% growth forecast for Chemicals industry in India. Consensus price target up from ₹678 to ₹753. Share price rose 9.6% to ₹708 over the past week. Price Target Changed • May 17
Price target increased to ₹753 Up from ₹678, the current price target is an average from 7 analysts. New target price is 6.3% above last closing price of ₹708. Stock is up 107% over the past year. The company is forecast to post earnings per share of ₹46.58 for next year compared to ₹38.71 last year. Reported Earnings • May 16
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: ₹38.71 (up from ₹25.40 in FY 2021). Revenue: ₹35.8b (up 49% from FY 2021). Net income: ₹3.49b (up 52% from FY 2021). Profit margin: 9.8% (in line with FY 2021). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 3.0%. Over the next year, revenue is forecast to grow 12%, compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Price Target Changed • Apr 27
Price target increased to ₹678 Up from ₹626, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of ₹658. Stock is up 112% over the past year. The company is forecast to post earnings per share of ₹37.57 for next year compared to ₹25.40 last year. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 7 highly experienced directors. Independent Non-Executive Director Sonal Desai was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Price Target Changed • Apr 09
Price target increased to ₹678 Up from ₹626, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of ₹705. Stock is up 129% over the past year. The company is forecast to post earnings per share of ₹37.57 for next year compared to ₹25.40 last year. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improved over the past week After last week's 16% share price gain to ₹626, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹515 per share. Major Estimate Revision • Jan 29
Consensus revenue estimates increase by 13% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from ₹30.6b to ₹34.7b. EPS estimate increased from ₹26.58 to ₹37.15 per share. Net income forecast to grow 17% next year vs 20% growth forecast for Chemicals industry in India. Consensus price target up from ₹452 to ₹626. Share price rose 58% to ₹601 over the past week. Reported Earnings • Jan 25
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Third quarter 2022 results: EPS: ₹11.33 (up from ₹5.35 in 3Q 2021). Revenue: ₹8.80b (up 78% from 3Q 2021). Net income: ₹1.02b (up 112% from 3Q 2021). Profit margin: 12% (up from 9.8% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 46%. Earnings per share (EPS) also surpassed analyst estimates by 144%. Over the next year, revenue is forecast to grow 5.0%, compared to a 20% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 19% per year. Price Target Changed • Jan 25
Price target increased to ₹542 Up from ₹452, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of ₹526. Stock is up 83% over the past year. The company is forecast to post earnings per share of ₹27.49 for next year compared to ₹25.40 last year. Valuation Update With 7 Day Price Move • Jan 24
Investor sentiment improved over the past week After last week's 19% share price gain to ₹438, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹440 per share. Reported Earnings • Oct 27
Second quarter 2022 earnings released: EPS ₹3.55 (vs ₹2.11 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹6.56b (up 54% from 2Q 2021). Net income: ₹320.2m (up 68% from 2Q 2021). Profit margin: 4.9% (up from 4.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.